VRAYLAR is a once-a-day medication, taken with or without food, for the treatment of schizophrenia in adults.
In clinical studies, VRAYLAR was proven to help manage the overall symptoms of schizophrenia.
People who took VRAYLAR experienced significant improvement in their overall schizophrenia symptoms compared to those who took a placebo (sugar pill).
This means that their symptoms of schizophrenia were less severe than the symptoms of people who took a placebo.
People taking VRAYLAR also showed a decrease in the overall severity of their condition based on a specific research tool used by healthcare providers. That’s good news, because taking VRAYLAR may help you manage your schizophrenia symptoms and could be an important part of your treatment plan.
Medicines like VRAYLAR start working gradually, so you may not see results right away. Every patient is different so it is important that you talk to your healthcare provider about how VRAYLAR is working for you. Don’t stop taking VRAYLAR without speaking to your healthcare provider first.
Sign up to learn more
See if you’re eligible to save on your VRAYLAR prescription
Knowing what to expect with treatment is important. Make sure to talk with your healthcare provider about the possible risks and side effects of VRAYLAR. The most common side effects of VRAYLAR in clinical trials were:
Before taking VRAYLAR, make sure your healthcare provider knows about any medical conditions and if you have or have had:
Tell your healthcare provider if you are pregnant or plan to become pregnant. Using VRAYLAR in the third trimester may cause uncontrolled movements of the body and the face, muscle stiffness, or feelings of restlessness and/or withdrawal symptoms in newborn babies. A special program (National Pregnancy Registry for Atypical Antipsychotics) collects information on the safety of antipsychotic drugs, including VRAYLAR, during pregnancy. For information, contact the program at 1-866-961-2388 or http://www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/.
Tell your healthcare provider about all medicines that you take or have recently taken. This includes prescriptions, over-the-counter medicines, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works.
VRAYLAR is an oral capsule that is taken with or without food. It is important that you take your prescribed dose of VRAYLAR as directed, even if you start to feel better.
Medications like VRAYLAR tend to work gradually, so it may take some time for you to notice your symptoms improve. That’s why it’s so important to take VRAYLAR exactly as prescribed.
Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat).
The most common side effects were uncontrolled movements of the face and body, muscle stiffness, and restlessness. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all possible side effects of VRAYLAR.
Have you ever wondered, “Could what I’m feeling be a side effect of my medication?” Call your healthcare provider right away and explain in detail what you are experiencing so they can tell you what to do. Always call your healthcare provider if you have questions about your medication or your dosing.
Weight gain has been reported with VRAYLAR. In 6-week clinical studies, patients with schizophrenia who took VRAYLAR experienced an average weight gain of about 2.2 pounds, compared to those on placebo who gained about 0.7 pounds
An increase in blood sugar has been reported with VRAYLAR. If you have diabetes or risk factors for diabetes (eg, being overweight or family history of diabetes), your blood sugar should be tested before you start VRAYLAR and regularly during treatment. Complications of diabetes can be serious and even life threatening. Tell your healthcare provider if you have symptoms such as feeling very thirsty or very hungry, urinating more than usual, or feeling weak
An increase in cholesterol has been reported with VRAYLAR. Your healthcare provider should check your cholesterol and triglyceride levels before and during treatment.
In the 6-week clinical study, 7% of patients with schizophrenia who took VRAYLAR felt sleepy or drowsy. In comparison, 6% of patients taking placebo felt sleepy or drowsy.
Feeling restless (akathisia) has been reported with VRAYLAR. In the 6-week clinical studies, 11% of patients with schizophrenia who took VRAYLAR felt restless.
Schizophrenia is a chronic condition. That means it’s lifelong and there is no cure. But for many people, the symptoms may be helped with treatment.
Schizophrenia is seen more often in people with a sibling or parent (a first-degree relative) who have the condition.
You may be eligible for a VRAYLAR savings card. Click here to learn more.
Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking antipsychotic drugs are at an increased risk of death. VRAYLAR is not approved for treating people with dementia-related psychosis.
Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat).
Tell your healthcare provider about any medical conditions and if you have or have had:
Tell your healthcare provider if you are pregnant, or if you plan to become pregnant. Using VRAYLAR in the third trimester may cause uncontrolled movements of the body and face, muscle stiffness, or feelings of restlessness and/or withdrawal symptoms in newborn babies. A special program (National Pregnancy Registry for Atypical Antipsychotics) collects information on the safety of antipsychotic drugs, including VRAYLAR, during pregnancy. For information, contact the program at 1-866-961-2388 or http://www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/
Tell your healthcare provider about all medicines that you take or have recently taken, including prescriptions, over-the-counter medicines, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all possible side effects of VRAYLAR.
VRAYLAR (cariprazine) is a once-a-day pill, taken with or without food, for the treatment of schizophrenia in adults.
Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking antipsychotic drugs are at an increased risk of death. VRAYLAR is not approved for treating people with dementia-related psychosis.
Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat).
Tell your healthcare provider about any medical conditions and if you have or have had:
Tell your healthcare provider if you are pregnant, or if you plan to become pregnant. Using VRAYLAR in the third trimester may cause uncontrolled movements of the body and face, muscle stiffness, or feelings of restlessness and/or withdrawal symptoms in newborn babies. A special program (National Pregnancy Registry for Atypical Antipsychotics) collects information on the safety of antipsychotic drugs, including VRAYLAR, during pregnancy. For information, contact the program at 1-866-961-2388 or http://www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/
Tell your healthcare provider about all medicines that you take or have recently taken, including prescriptions, over-the-counter medicines, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all possible side effects of VRAYLAR.
VRAYLAR (cariprazine) is a once-a-day pill, taken with or without food, for the treatment of schizophrenia in adults.
